Back to Journals » ClinicoEconomics and Outcomes Research » Volume 14
Original Research
Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,826 | Dovepress* | 6,380+ | 444 | 6,824 | |
PubMed Central* | 446 | 100 | 546 | ||
Totals | 6,826 | 544 | 7,370 | ||
*Since 2 May 2022 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 2 | 4 |
View citations on PubMed Central and Google Scholar